This study aimed to determine the time-dependent effects of diaphragmatic inactivity on its maximum shortening velocity (V max ) and the Muscle Atrophy F-box (MAF-box, atrogin-1) gene expression during controlled mechanical ventilation (CMV).
INTRODUCTION

Previous studies have demonstrated that controlled mechanical ventilation (CMV)
produces a rapid loss in diaphragmatic function as defined by maximal isometric tension (P o ) (13, 20, 28, 35, 36, 40) . This phenomenon has been described as ventilator-induced diaphragmatic dysfunction (VIDD). The majority of these studies to date, however, have focused primarily on isometric contractile properties (13, 20, 28, 35, 40) , and, as a consequence, the true scope of functional impairment is yet to be clearly defined. As we have noted previously (6, 9) , the force-velocity relationship is one of the most important mechanical properties of skeletal muscle, because it describes the maximal force that a muscle can generate at any given shortening velocity. The shape of the force-velocity relationship reflects the kinetics of crossbridge cycling, and changes in this relationship provide important clues about alterations in the underlying molecular events controlling the production of P o and maximal shortening velocity (V max ).
Given the background above, there are a number of unresolved issues related to the functional consequences of CMV. For instance, in a previous study we observed that CMV seemed to produce an increase in V max that occurred without commensurate changes in myosin isoform composition as examined at both the heavy and light chain levels (36) . Hence, in the current study, we address this issue again in an attempt to either confirm or reject the hypothesis that CMV increases V max and alters the shape of the force-velocity relationship in the low force-high velocity region. This is an important issue to be resolved because an increase in V max without concomitant changes in myosin isoform composition would suggest that other factors such as altered myofibrillar ultrastructure may be responsible for the noted changes in V max (5) . Additionally, while it has been shown that CMV produces a significant degree of myofibrillar disarray (1, 30, JAP-00126-2005 . R1 4 35) , it is unclear what underlying mechanisms are responsible for this phenomenon. In our earlier study (36) , we observed that 3 days of CMV dramatically increased the expression of Muscle Atrophy Factor-box (MAF-box; also known as atrogin-1), an E3 ligase in the ubiquitin-proteasome pathway. MAF-box has been shown to play an important role in the development of muscle atrophy under a variety of altered physiological conditions, and, as such, may play a key role in mediating changes in both P o and V max induced by CMV.
We addressed these issues in the current study by employing a time-course paradigm whereby the diaphragm underwent 1, 2, and 3 days of CMV. At the functional level, we performed regression analyses to test the hypothesis that increases in V max following CMV are correlated to myofibrillar disarray. With respect to MAF-box, we used time-course analyses to determine if elevations in MAF-box precede or follow the appearance of myofibrillar derangement. This approach is essential for testing the hypothesis that increased MAF-box expression is partially or completely responsible for the development of VIDD.
MATERIALS AND METHODS
Animal preparation and surgical procedures
The Research and Development Subcommittee on animal studies of the Veterans Affairs Long Beach Healthcare System approved the study. We studied 24 adult male New Zealand White rabbits. The animals were assigned randomly into four groups: 1) control; 2) 1 day CMV; 3) 2 day CMV; and 4) 3 day CMV. Six animals were assigned to each group. Pressure-limited ventilation (model 7200ae Nellcor-Puritan Bennett or model 840 Nellcor-Puritan Bennett, Tyco Healthcare, Carlsbad, CA) was applied in the JAP-00126-2005.R1 5 CMV groups. The ventilator inspiratory pressure, inspiratory time, and rate were set as previously described (35, 36) . The latter was set sufficiently high to suppress inspiratory efforts, as detected from the inspiratory flow waveform (35) . The inspired air was humidified, positive-end expiratory airway pressure was set at 0 cm H 2 O, and inspired O 2 fraction was set to maintain arterial PO 2 at greater than 60 torr. The animals in the CMV groups were euthanized following the completion of a given period of CMV (i.e., 1, 2, or 3 days). The control group was euthanized after the surgical procedure was completed.
We did not include a sham control group consisting of sedated animals breathing spontaneously for the respected duration of CMV because we have previously shown that anesthetic or sedative drugs did not have any influence on the effect of mechanical ventilation on diaphragmatic function (35) .
The surgery was performed under general anesthesia using aseptic techniques.
The initial dose of anesthetics consisted of ketamine hydrochloride (35 mg/kg) and xylazine (5 mg/kg) administered intramuscularly. During the surgical procedure, a maintenance dose of ketamine hydrochloride (2 mg/kg)-xylazine (0.2 mg/kg) was administered intramuscularly every 20 minutes as needed. The depth of anesthesia was monitored by the absence of jaw tone. The trachea was cannulated with a tracheostomy tube (4 mm ID, 6 cm long) through a tracheostomy incision. The external jugular vein was cannulated for continuous infusion (lactated Ringer, 100 ml/kg/day) and intravenous medications. The common carotid artery was cannulated for blood pressure (model P23XL Grass, Astro-Med, West Warwick, RI) and for heart rate monitoring and arterial blood sampling, as previously reported (35, 36) . A feeding tube was inserted into the stomach via a small incision in the esophagus. Prealbumin measurements were obtained in the controls and animals receiving 3 days of CMV only, since prealbumin half-life is JAP-00126-2005.R1 6 48 hours (19) , and therefore, meaningful changes will be detected at 72 h. After the surgical procedures, the skin was closed in layers, except for the control group.
Animal monitoring during mechanical ventilation
During CMV, continuous intravenous sedation was maintained with diazepam at a loading dose of 4 mg/kg intramuscularly, followed by a continuous intravenous infusion of 2-5 mg/h titrated to limb movement. This diazepam dose was insufficient to suppress the respiratory center. Suppression of the diaphragm was maintained by adjusting the ventilator settings and if necessary, by administration of additional maintenance doses of a ketamine-xylazine mixture. The following medications were also given: buprenorphine (0.05 mg/kg sc) every 12 hours for analgesia, atropine sulfate (0.02 mg/kg sc) every 12 hours to reduce bronchial secretions, and penicillin G procaine (300,000 U intramuscularly) every 12 hours to prevent infection. To prevent metabolic acidosis, sodium bicarbonate was administered (1-3 meq/h iv), titrated according to arterial pH (37) . Electrolytes were maintained and liquid enteral nutrition (F3978SP, BioServ, Frenchtown, NJ) was delivered through the feeding tube at 25 cal/kg/day in 6 equally divided doses. Blood pressure and heart rate were continuously monitored. The analog signals were displayed in real time on a computer monitor of a data acquisition system and recorded every 2 hours (WinDaq/Pro, Dataq Instruments, Akron, OH).
Rectal temperature was continuously monitored and maintained at 36-38ºC with a heating 
In vitro measurements of diaphragm contractile properties
Isometric contractile properties: At the end of the experiments, the animals were euthanized with an overdose of pentobarbital sodium (100 mg/kg iv). The diaphragm muscle was rapidly excised from the midcostal region, with the insertion of fibers at the ribs and central tendon intact. A diaphragm muscle strip (~ 5 mm wide) was obtained and mounted vertically between two platinum plate electrodes that covered the entire length of the muscle strip in a 26ºC bath containing Rees-Simpson solution (39) through which 95% O 2 -5% CO 2 was continuously aerated, maintaining a pH of 7.40. The rib end of the muscle was clamped, and the central tendon of the muscle was attached to a calibrated lever of a Cambridge system (Model 300B, Aurora Scientific, Inc) to allow adjustment of muscle length. The muscle was stimulated using 1.5 ms duration of monophasic rectangular pulses delivered via a current amplifier (Mayo Foundation, Engineering Section), which was controlled by a Grass S88 stimulator (Astro-Med, Inc).
Current intensity was adjusted until maximum tetanic force (at 50 Hz and train of 500 ms) responses were obtained. Thereafter, the stimulus intensity was set at 125% of this JAP-00126-2005.R1 8 value. Muscle preload was adjusted by using the micromanipulator until L o , the length at which the muscle produces maximal isometric tension, was achieved. Subsequently, L o was measured using digital calipers. At L o , peak twitch tension (P t ), time to peak twitch tension (TPT), and RT½ (the time for Pt to relax to one-half P t ) were determined from a series of contractions induced by single-pulse stimuli. Isometric and isotonic force generations were determined using the Cambridge system, controlled using customized routine software (LabTech Notebook, Andover, MA) and implemented on a personal computer. The analog-to-digital board (MetraByte DAC-16) sampled the force and length outputs at a frequency of 1000 Hz/channel. To determine maximal isometric tetanic tension (P o ), the muscle strip was stimulated using trains of 1 second at 40, 50, 75 and 100 Hz with at least a 2-minute interval between each stimulus frequency. Forces were normalized for muscle cross-sectional area, which was estimated using the following formula: muscle mass (g) / [L o (cm) x muscle density (g/cm 3 )], where 1.056 g/cm 3 was used for muscle density.
Isotonic contractile properties:
Following isometric force measurements, the muscle strip was allowed to equilibrate for 15 minutes prior to measurement of isotonic contractile properties. The force-velocity relationship was determined using the isotonic mode of the Cambridge system with computer-controlled afterload. The muscle was tested at a minimum of 15 different afterload conditions (1.0 -100% P o ). The muscle began each contraction at L o . The shortening velocity at each afterload was determined by calculating the slope of the length versus time record over successive 10 ms segments.
The segment with the greatest slope was used as the velocity of measurement for that specific load. Force-velocity data were then fitted to a linearized form of the Hill equation (17) . The least-squares technique was used to find the best fit to this equation.
JAP-00126-2005.R1 9
This procedure involved an iterative regression routine that began with an initial value for a, and performed 100 successive iterations using a specified incremental factor for a. The computer program identified the best fit for the force-velocity data by determining which values of a and b provided the smallest sum of squares between the measured and predicted velocities. Maximum shortening velocity (V max ) was determined using the Hill equation and solving for velocity when force equaled zero. Velocity of contraction, expressed as muscle length (normalized for L o ) per second (ML/s), was plotted against force. Power, the product of force and velocity of contraction, expressed as Watts/kg of muscle wet weight, was calculated and plotted against force. In addition, the maximum or peak power output was determined.
Determination of abnormal myofibrils
A segment of diaphragm muscle strip was obtained for electron microscopy (EM) from 4 animals in each group. The muscle strip was stretched to 1.5 times the resting excised muscle length (approximate optimal length for muscle force generation) (29) 
Contractile protein and molecular analysis
Quantification of contractile protein fractions. Tris, 5% glycerol, 4% SDS, 0.05% bromophenol blue, and 5% beta-mercaptoethanol. At the completion of electrophoresis, gels were stained for 1 hour with R-250 Coomassie Blue, and then destained using a 40% methanol/10% acetic acid solution. Gels were then digitally imaged and analyzed using ImageQuant software (Molecular Dynamics, Sunnyvale, CA). We obtained the relative proportions of myosin and actin by measuring the density of each contractile protein band and expressing it as a percentage of the total density of all proteins in that sample.
Discontinuous polyacrylamide gel electrophoretic (PAGE) separation of myosin heavychain (MyHC) isoforms.
MyHC protein isoforms were separated using techniques described by us previously (7, 8 Scientific Company, Inc., Del Mar, CA) was used for electrophoresis. Gels were run for ~24 hours, and at 270 V. MyHC protein isoform bands were stained using a silver stain kit (BioRad, Richmond, CA). The MyHC isoform bands were digitally imaged and quantified using ImageQuant software (Molecular Dynamics, Sunnyvale, CA).
Determination of Myosin Light-Chain (MyLC) isoforms.
Analyses of MyLC protein isoform composition were performed as described previously (9) . Purified myofibrillar protein from each sample was denatured and loaded (5-10 µg) into the well of a 5-20% gradient gel. The gels were run using a constant current of 50 mA per gel for a period of ~1 hour. The MyLCs were identified using known molecular weight markers. The gels were fixed and stained using R-250
Coomassie Blue. The MyLCs were digitally imaged and quantified using ImageQuant software (Molecular Dynamics, Sunnyvale, CA). Data for a given essential MyLC isoform was expressed relative to the total area for all the essential light chains, that is, and fast MyLC 2 (fMyLC 2 ).
Determination of MyHC isoforms and MAF-box mRNA using reverse transcription (RT) coupled with polymerase chain reaction (PCR).
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One µg of total RNA was reverse-transcribed for each muscle sample using the Superscript II RT and a mix of oligo dT (100 ng/reaction) and random primers ( ribosomal RNA was co-amplified with the target cDNA (mRNA) to serve as an internal standard and to allow correction for differences in starting amounts of total RNA. The Classic 18S and Alternate 18S were used for the PCR reaction with MyHC and MAFbox, respectively. The PCR conditions for each primer set and 18S competimer were optimized, so that the target mRNA and 18S products were in the linear range. For each specific target mRNA, the RT and PCR reactions were carried out under identical conditions. One µl of each RT reaction without dilution was used for the PCR with an initial denaturing step of 2 minutes at 95ºC, followed by 26 cycles of 45 seconds at 95ºC, 1 minute at 55ºC, 90 seconds at 72ºC, and a final step of 5 minutes at 72ºC. PCR products were separated on a 2.0% agarose gel by electrophoresis and stained with ethidium bromide, and signal quantification was conducted by laser scanning densitometry. In this approach, each specific mRNA signal was normalized to its corresponding 18S. In addition to the diaphragm muscle, we analyzed the MAF-box mRNA of the medial gastrocnemius muscle in 4 of the animals in the 1 day, 2 days and 3 days of CMV, and all of the animals in the control group.
Statistics and data analyses
Values are means ± SE unless specifically indicated. A one-way ANOVA (SigmaStat, version 3.0, SPSS Science, Chicago, IL) was used for comparison of variables among groups. When the F value was significant, post hoc analysis was performed using Tukey test for pair wise multiple comparisons. A linear regression was used to determine the relationship between abnormal myofibrils and P o and V max . A similar regression analysis was performed to assess the relationship between MAF-box mRNA levels and the volume density of abnormal myofibrils. Group differences and linear regression were considered significant when P ≤  0.05.
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RESULTS
Mean values of body weight and prealbumin of the 3 day CMV group were not significantly different from those of the control group (Table 1) . The controls and the initial blood gas values of all of the CMV groups demonstrated metabolic alkalosis as previously shown (36) . Following the application of CMV, respiratory alkalosis and metabolic acidosis developed, but within the range previously reported (35, 36) , independent of the duration of mechanical ventilation ( Table 1 ). The measured lactic acid was not significantly different at the end of the experiments: 2.0 ± 0.7, 3.0 ± 1.1, 4.0 ± 0.8, and 3.4 ± 0.8 (± SE) mmol/l for the control, 1 day, 2 day, and 3 day CMV groups, respectively.
Diaphragmatic contractile properties
The stability of the muscle preparation was evaluated by comparing measurements of Po. The initial measurements of Po were made once the muscle strip preparation was properly attached to the Cambridge ergometer system and Lo was determined. The mean values for the control, 1 day, 2 day, and 3 day of CMV groups were 25.9, 19.3, 16.9, and 15.4 N/cm 2 , respectively. Po was again measured just prior to force-velocity measurements, and the mean values for the four groups were 25.3, 19.1, 17.8, and 15.6 N/cm 2 (control, 1 day, 2 day, and 3 day groups, respectively). Table 2 shows that L o , TPT and RT½ were not significantly different among groups, while P t and P o decreased by 39% and 44% after 3 days of CMV, respectively (P < 0.01). V max increased progressively from a mean control value of 6.4 ML/s to 6.6, 7.7 and 8.1 ML/s after 1, 2 and 3 days of CMV, respectively (P < 0.02; see also top panel of Figure 1 ). Figure 1 shows the entire force-velocity and force-power relationships for the JAP-00126-2005.R1 16 different groups. When force is expressed as percentage of P o , it is clear that the increases in shortening velocity partially compensated for the loss of force such that the reduction in maximal power was minimized ( Figure 1 , bottom panel).
Contractile protein isoforms
As shown in Table 3 , CMV did not affect the relative proportions of myosin heavy chain and actin protein pools (expressed relative to the total pool of contractile proteins). Similarly, the MyHC isoforms mRNA levels were unaltered ( Figure 2 ). Figure 3 demonstrates that MAF-box mRNA levels of the diaphragm were significantly increased, 355 % of control at the earliest time-point (i.e., 1 day), and remained elevated at both the 2 day (365 %) and 3 day (260 %) time-points as well. The pairwise comparison of 3 day CMV and control was significant at P = 0.07; however, the degree of elevation was consistent with that observed in our previous study of 2.7-fold of the control value (36). If we combine the MAF-box mRNA data of 3 day CMV of prior and current studies, the difference between the control and the 3 day time point was significant at P < 0.01. Unquestionably, MAF-box mRNA increased early in the course of CMV and maintained elevated for the duration of its application.
MAF-box mRNA levels
As a group, the MAF-box mRNA levels of the medial gastrocnemius muscle after 1 day, 2 days and 3 days of CMV were elevated from control (1.6-fold) (P < 0.04), however, the pairwise comparisons were not significantly different ( Figure 3 were significantly less than those of the diaphragm at both day 1 and 2 (P < 0.03).
Diaphragmatic ultrastructure alterations
The volume density of abnormal myofibrils (compared to the control group) was unchanged following 1 day of CMV (see Figures 4 and 5) . However, the presence of 
Relationships between myofibrillar disarray and measurements of P o and V max .
As shown in Figure 6 , there was a significant correlation between the volume density of abnormal myofibrils and the loss of P o (r = 0.64; P<0.01). The correlation between the volume density of abnormal myofibrils and V max was even stronger, accounting for 76% of the variance in V max (r = 0.87; P<0.01).
DISCUSSION
Three distinct findings emerged from the present study. First, we observed that 
Functional consequences of CMV and potential structural basis.
Previous studies have conclusively shown that CMV produces a rapid and dramatic decrease in the ability of the diaphragm muscle to produce isometric tension.
One might assume that this type of ventilator-induced diaphragmatic dysfunction also applies to other loading conditions within the force-velocity relationship. Interestingly, however, the findings of the current study as well as our previous publication (36) , demonstrate that CMV produces a compensatory phenomenon in the low force-high velocity region of the force-velocity relationship. The functional consequences of this compensatory phenomenon (within the context of the force-velocity relationship; see In a previous study (36) , we observed that 3 days of CMV produced a significant reduction in maximal power. In the current study, we again found that the mean maximal power value of the 3 day CMV group was less than that of the control group. However, the degree of change (~11%) was not large enough to be statistically significant. If we combine the findings of the current study with those of our previous publication (36), then it is clear that CMV does reduce maximal power. As emphasized above, however, the changes in the low force-high velocity region of the force-velocity relationship in the CMV diaphragm muscles help to minimize the degree to which maximal power is reduced.
Since the late 1980s, a number of single fiber and whole muscle studies (4, 12, 14, 31, 34) attempted to identify the underlying mechanisms responsible for determining maximal shortening velocity, as defined by either extrapolation of the force-velocity relationship or slack tests. Currently, it is commonly accepted that the myosin heavy chain isoform composition of a fiber/muscle is the primary determinant that accounts for the differences in V max between slow and fast muscle. Importantly, however, it should be noted that Riley et al. (32, 33) observed that V max or the maximal unloaded shortening velocity (V o ) can be altered under abnormal physiological conditions independent of changes in myosin isoform composition, and it has been suggested that the increases in JAP-00126-2005.R1 20 V max observed by these investigators occurred as a result of altered myofilament ultrastructure. Interestingly, the findings of the current study are somewhat analogous to those of Riley et al (32, 33) . Specifically, we observed an increase in V max that appears to be correlated with the degree of abnormal myofibrils and not to changes in myosin isoform composition. Riley et al. (32, 33) suggested that muscle unloading produces myosin-independent changes in V max by selectively reducing the thin filament density.
While we did not specifically address this issue at the EM level, our protein analyses at the whole muscle level demonstrate that there was not a selective reduction in actin to myosin ratio. Nevertheless, the collective findings of our studies and those of Riley and coworkers (32, 33) , demonstrate that reduced loading/activation of skeletal muscle can produce increases in V max that appear to be related to altered ultrastructure and not to changes in myosin isoform composition. Clearly, more detailed analyses are needed to better define the underlying causes of this phenomenon.
As noted above, the most profound functional consequence of CMV is the large reduction in P o . In the current study, we observed that the increased volume density of abnormal myofibrils could account for approximately 40% of the loss of P o ( Figure 6 left panel). Additionally, Figure 6 shows a significant reduction in P o at the 1 day timepoint that occurred in the absence of detectable changes in ultrastructure. Some possible reasons for the absence of a stronger relationship might be as follows. First, determining the loss of abnormal myofibrillar volume density may not accurately describe the full extent of myofibrillar dysfunction (as is probably the case). For instance, we did not examine possible changes in thin filament density or thin filament structure as attempted by Riley et al. (32, 33) . Second, CMV might alter the excitability and/or excitationcontraction coupling of diaphragm muscle. To our knowledge, the effects of CMV on JAP-00126-2005.R1 21 these two key processes are unknown. It has been shown however, that mechanical unloading of rodent hindlimb muscles does not alter Ca ++ handling in a manner that can account for the large loss observed in P o as in the current study (18) . Clearly more detailed analyses are needed to: 1) better delineate the functional cellular/molecular defects; and 2) to isolate the underlying cellular/molecular mechanisms responsible for inducing such functional defects.
Time course of Muscle Atrophy Factor-box expression
With respect to the second consideration above, it is clear from the EM analyses of the current study (35) that one of the primary defects produced by CMV is myofibrillar disarray. The factors responsible for producing this disarray represent an important area of investigation. Currently, it is thought that there are at least three degradatory pathways that might mediate the extent of VIDD and these include: 1) increased degradation via oxidative stress (2, 38, 42) ; 2) the involvement of calcium-activated proteases (38) ; and 3) the ATP-dependent ubiquitin-proteasome pathway (11, 36) .
In skeletal muscle, the majority of intracellular proteolysis is thought to occur through the ubiquitin-proteasome system (23) . Muscle proteins destined for degradation by the ubiquitin-proteasome pathway are first covalently linked to a chain of ubiquitin molecules that marks them for proteolysis by the 26S proteasome (15) . One key set of enzymes responsible for attaching ubiquitin to protein substrates is the ubiquitinconjugating enzymes (E3s). Three of these have been identified to play key roles in the activation of proteolysis during muscle atrophy. E3α (also called Ubr1/Ubr2) acts on proteins with basic and large hydrophobic NH2-terminal amino acids (termed the "N-end rule pathway") (21) . The other two E3 ligases, MAF-box and muscle ring finger-1 JAP-00126-2005.R1 22
(MURF-1), were recently discovered in skeletal muscle (3, 16) , and shown to be dramatically over expressed in all forms of muscle wasting studied in rodents including mechanical unloading (3). Furthermore, following hindlimb denervation, knock out mice lacking these enzymes show reduced muscle atrophy (3).
Currently, there are four key findings that support the hypothesis that MAF-box plays a role in mediating the development of VIDD. First, in a previous study (36) , we found that 3 days of CMV produced a large increase in the mRNA levels of MAF-box. A more recent study by Deruisseau et al. (11) examining rat diaphragm muscle also made similar observations. Second, we observed that assisted mechanical ventilation (AMV) markedly attenuated the loss of diaphragm function that results from CMV. Importantly, we also found in this same study that MAF-box mRNA levels were unaffected in the AMV group, i.e., they did not increase above baseline values. Third, in the current study, we found that MAF-box mRNA levels were elevated prior to the appearance of ultrastructural derangement. Finally, Deruisseau et al. (11) recently observed that CMV produces an increase in the presence of ubiquitin-protein conjugates (both myofibrillar and cytosolic). These correlative findings represent an important set of data necessary for establishing a causal role for MAF-box and the ubiquitin-proteasome pathway in mediating the deleterious effects of CMV. These findings, however, need to be complemented by more mechanistic studies whereby MAF-box and other components of the ubiquitin-proteasome system can either be over or under expressed.
The modestly increased MAF-box mRNA in the gastrocnemius does not repudiate the hypothesis on the role of the ubiquitin-proteasome pathway in mediating the development of VIDD. The highly elevated MAF-box mRNA levels in the diaphragm suggest that the diaphragm muscle is more sensitive to alterations associated with disuse JAP-00126-2005.R1 23 than the hindlimb muscle. Whether the increased sensitivity of the diaphragm muscle to disuse is related to its prior activation history, is unclear.
Important technical considerations and limitations
Some might question whether the acid-base disturbances observed in the current study might explain some or all of the loss in diaphragmatic function due to CMV. As we have noted previously (35) , in which a spontaneous breathing control group was available for the same duration of the study as the CMV group, the acid-base status had no effect on diaphragmatic force. Similarly, previous studies in which metabolic acidosis was induced, diaphragm muscle force was maintained provided the pH was greater than 6.8, (10) or when respiratory acidosis was nonexistent (41) . Furthermore, metabolic acidosis did not activate the ubiquitin-proteasome pathway (26) .
It has been shown that muscle atrophy is associated with the upregulation of both MAF-box and Murf-1 mRNA levels. Our analyses in the current study were restricted to MAF-box because we have been unable to develop a suitable Murf-1 oligonucleotide for rabbit muscle. It should be noted, however, that Deruisseau et al. (11) recently reported that mechanical ventilation produced an increase in Murf-1 mRNA levels in rat diaphragm muscle.
Summary
The force-velocity data of the current study clearly demonstrate that the dysfunction produced by CMV is profound and negatively impacts function throughout 80-90% of the force-velocity relationship. At the structural level, the dysfunction appears to be the result of extensive myofibrillar disarray. Importantly, we observed that CMV afflicted with conditions such as sepsis, insulin resistance, uremia, and malnutrition (22) .
Each of these individual conditions is known to accelerate proteolysis through the ubiquitin-proteasome pathway (22, 24) .
FIGURE LEGENDS Figure 1:
Force-velocity and force-power relationships of the diaphragm in control, 1 day, 2 day, and 3 day of CMV groups. Note that force is expressed as N/cm 2 in the top panel and as percentage of maximum tetanic force (i.e., relative to P o ) in the bottom panel. P < 0.02, for maximum shortening velocity after 3 day of CMV versus control (see Table 2 ).
Power was not significantly different among groups. Definition of abbreviation: CMV = controlled mechanical ventilation. In control group arterial blood gas tension was obtained during spontaneous breathing.
Values are mean ± SE, except for body weight (± SD). *P < 0.05 compared to controls.
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